530803

CARE Ratings has reaffirmed Bhageria Industries Ltd's credit rating at CARE A; Stable / CARE A1 for bank facilities amounting to ₹141.00 Crores (enhanced from ₹91.00 Crores). - The rating has been removed from 'Rating Watch with Negative Implications' and assigned a 'Stable' outlook. - The review considered the operational and financial performance for FY26 and Q1FY27, along with restart permission for the sulphonation section of the H-acid manufacturing unit from MPCB.

- CARE Ratings has reaffirmed Bhageria Industries Ltd's credit rating at CARE A (Stable) / CARE A1 for its bank facilities worth ₹91.00 Crores. - The ratings have been removed from 'Rating Watch with Negative Implications' and a 'Stable' outlook has been assigned. - The rating action follows operational and financial performance review and restart permission for the sulphonication section of the H-acid manufacturing unit from MPCB.

- Bhageria Industries Limited responded to BSE and NSE queries dated September 21, 2026, regarding significant volume movement in its security. The company confirmed compliance with SEBI Listing Regulations and stated no pending information or announcement that could affect the price/volume behavior.

- Bhageria Industries Limited announced the closure of its trading window for designated persons and their immediate relatives. - The closure is effective from October 1, 2026. - The trading window will reopen 48 hours after the declaration of Unaudited Financial Results for the quarter ended September 30, 2026.

- The 37th Annual General Meeting (AGM) of Bhageria Industries Limited was held on August 1, 2026. All agenda items were passed with requisite majority. This included the adoption of the Audited Financial Statements for the financial year ended March 31, 2026, and the declaration of dividend for the same period. Re-appointments of key directors were also approved.

- The 37th Annual General Meeting (AGM) of Bhageria Industries Limited was held on August 1, 2026, through Video Conferencing. - All items of the Agenda, including the adoption of audited financial statements for FY2026, declaration of dividend for FY2026, re-appointment of directors, and appointment of Cost Auditors for FY2026-27, were passed with requisite majority. - The Statutory Auditors and Secretarial Auditor reports for FY2026 had no qualifications or observations.

- Update on Securities Appellate Tribunal (SAT) matter regarding Promoters'/Directors' challenge to SEBI adjudication order dated March 31, 2023. - The matter was adjourned on July 28, 2026. - Next hearing for final disposal is scheduled for October 21, 2026. - The SEBI order dated March 31, 2023, remains stayed until final disposal.

- Consolidated Revenue ₹286.42 Cr vs ₹157.48 Cr (▲81.87% YoY) - EBITDA ₹57.64 Cr vs ₹24.17 Cr (▲138.46% YoY) - PAT ₹33.91 Cr vs ₹10.88 Cr (▲211.60% YoY) - EBITDA Margin 20.12% vs 15.35% (▲477bps)

- Standalone Operating Revenue ₹300.78Cr vs ₹164.75Cr (▲82.56% YoY) - EBITDA ₹40.06Cr vs ₹18.25Cr (▲119.47% YoY) - PAT ₹35.94Cr vs ₹11.99Cr (▲199.78% YoY) - EBITDA Margin 13.32% vs 11.08% (▲224bps)